# Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer

> **NCT00405405** · PHASE1 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University** · enrollment: 13 (actual)

## Conditions studied

- Head and Neck Cancer
- Parotid Gland Cancer
- Thyroid Gland Cancer
- Melanoma
- Stage IV Head and Neck Cancer

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Docetaxel
- **DRUG:** Bevacizumab
- **DRUG:** Erlotinib
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT00405405
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2025-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00405405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00405405, "Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00405405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*